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                                                                              :         ABSTRACT  
  
Background: The metabolic syndrome has received increased attention in the past few years because it was 
considering a public health issue in both developed and developing countries. It is an unfavorable cluster of 
factors that increases the risk from cardiovascular disease, stroke, and type-2 diabetes. There were many criteria 
to define it, but all of these criteria agreed on core component of metabolic syndrome which is obesity, 
dyslipidemia (increase triglycerides and decrease High-Density Lipoprotein cholesterol), hypertension and 
diabetes mellitus type 2.                                 
Aims: for the evaluation the risk factors that may be responsible for development of metabolic syndrome in 
Babylon city.        
                                                             : Across sectional study carried out to the randomly Patients and Methods
selected patients attending Merjan teaching hospital in Babylon, within the period from first of April to thirty of 
June, 2012. Data obtained included questionnaires, measurement of anthropometric and blood pressure with 
laboratory investigation.                                                                   
Results: This study shows the risk score for metabolic syndrome as follows, the low-risk score about [31.1%], 
moderate risk about [50.8%] and the high risk about [18.1%]. There was significant association for the risk of 
metabolic syndrome with the age and significant association of risk groups with hypertension, triglyceride, 
overweigh (BMI>25kg/m2), central obesity, diabetes millets, and low high density                                 
Conclusions: There was increased in risk of metabolic syndrome with an increased number of risk factors and 
with progression of the age in Babylon. 
 
 
-Introduction: 
                            Metabolic syndrome (MS) also known as syndrome X, insulin resistance syndrome, Reaven's 
syndrome, cardio metabolic syndrome, or dys metabolic syndrome [1, 2]. MS is defined as clusters  of 
individual's risk factors that increase the risk for developing cardio vascular disease (CVD)and Diabetes Mellitus 
DM type 2 [1-3].  The National Cholesterol Education Program's Adult Treatment Panel III (NCEP-ATP III) 
define this syndrome as it consists of multiple, interrelated risk factors of metabolic origin that appear to directly 
promote the development of atherosclerotic cardiovascular disease. Five factors are thought to comprise this 
syndrome, and it was defined when three or more of the following abnormalities are present, which are: 
abdominal obesity with a waist circumference for men >102 cm and women >88 cm, serum triglycerides =150 
mg/dl (= 1.7 mmol/l), high-density lipoprotein (HDL) cholesterol for men <40 mg/dl ( < 0.9 mmol/l  and for 
women <50 mg/dl (< 1.0 mmol/l), blood pressure =130/85 mmHg, and fasting plasma glucose =110 mg/dl(6.1 
mmol/l) [2,4,5]. Other major risk factors that may increase  the risk of MS include physical inactivity, an 
unhealthy diet (like high carbohydrate and saturated fat diet), cigarette smoking, and increased aged [1,3,4]. The 
studies shows that the patients with MS, there are 30% to develop CVD and 50% to die from it, when compare 
with a patient have no MS [6,7,8].           The MS is not new, having been already observed in 1920s by Kylin, 
who described the clustering of hypertension, hyperglycemia, and gout as a syndrome [1, 6], but in 1980, this 
association became more clearly defined, and the term MS was used [9, 10].  In 1988, Gerald Reaven, a pioneer 
scientist and expert in the field of metabolism noted this clustering and he Called Syndrome X, and he 
recognized it as a multiplex risk factor for (CVD) [6, 9].                                                                            
        In Iraq, there are few population-based  studies   on  MS .One of them in Babylon city [11] about 
prevalence of MS in a patient with DM type 2, found about 66.5% of DM type 2 have MS [2,11]. other study 
done in AL-Basrah city found overall prevalence of MS was 86% of the patient have DM type2 [13]. Another 
study done in Baghdad in the Ibn albetar hospital about the prevalence of MS in a patient have (IHD) found that 
the overall prevalence of metabolic syndrome was 69.33 % [12]. There is an increase in prevalence of MS with 
age and mainly effect on female in postmenopausal [14], and there are slight differences between the incidences 
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of MS among male and female before that age [4]                                                                                                                            
Definition of Metabolic syndrome  
MS is a non-communicable, non-infectious disease, and according to the (WHO) recent update, considers the 
chronic disease which compose of MS are one of the top five continuing risk factors for cardiovascular deaths in 
the world [15], and the global prevalence of chronic diseases is projected to increase substantially over the next 
two decades to about 60% in developing countries, and CVD is already the leading cause of mortality [16, 17].                                                             
1-2 Epidemiology of Metabolic Syndrome:   
              Worldwide prevalence of metabolic syndrome ranges from <10% to as much as 84%, depending on age, 
region, urban or rural environment, ethnicity, and the criteria of metabolic syndrome used[18, 19]. It was 
estimated that around 20-25% of the world’s adult population have the MS [4] also it was recorded that there is 
high prevalence of the MS and its key cardiovascular risk factors (15-60%) among Middle East population [18].   
         Accordingly ( in the Arab world) the prevalence of MS  varies widely, it was about 17% among 
Palestinians, 21% in Omani [20],  from 20.8% to 39.3% in Saudi Arabia [2] and in Northern Jordan was 36.3% 
with a significantly higher prevalence in women than in men[18].It is about 46% in Yamani people, in Kuwait 
about18%[20],while from 23.1 to 33.7 in different parts of Iran [2].In Tunis, MS prevalence was 45.5% and in 
Turkey reported that the prevalence of MS was 33.9% [18].                                                                                                                       
While in the developed country approximately 20%-30% of the populations have MS [15]. In the US, about 
25%-35% of American adult had MS and UK research suggests a similar numbers of peoples are affected in US 
[2 ,14, 21].  
         It was found that, the prevalence of MS increased with age affecting about 3-4% in younger age group and 
between (25- 40%) in elderly [2,15, 20]and there are slight differences according to gender (24%) in male and 
(23.4%) in female [11, 22].  
Causes of Metabolic Syndrome: 
                  MS is multi factorial; a combination of both metabolic and underlying risk factors is involved [23]. 
Genetics and the environmental factors both play important roles in the development of the MS in which the 
genetic factors influence each individual component of the syndrome [8]. A family history of type 2 DM, 
hypertension, and early heart disease greatly increase the chance that                                         an individual will 
develop the MS [8,10,17].                                     
                                             Environmental factors such as sedentary lifestyle, progressive weight gain and 
unhealthy diet that rich with carbohydrate and fat also contribute significantly to the risk of developing the MS 
[10, 15]     
Criteria for clinical Diagnosis of MS:     
           Although the risk associated with the MS is well-documented, the criteria of the syndrome are still in flux. 
In 1998, the (WHO) proposed a set of diagnostic criteria of MS based on insulin resistance [5, 8, 9]. It is 
included micro albuminuria, which does not appear in the later definitions [18]. In 1999, followed by definitions 
from the European Group for the Study of Insulin Resistance (EGIR) and its definition did not include diabetic 
patients [18].At 2001, the MS defined by the National Cholesterol Education Program's Adult Treatment Panel 
III (ATP III). The 2001 ATP III definitions have been regarded as probably the most practical for alerting 
clinicians to a patient at risk [8, 14, 22]. In 2005, the modification to 2001, ATP III definitions of MS by the 
American Heart Association and National Heart, Lung, and Blood Institute (AHA/NHLBI) were published. The 
2001 ATP III criteria were maintained except for a reduced threshold for hyperglycemia that 100 mg/dl is the 
new set point for fasting glucose and referred to as the     Modified ATPIII definition [1, 8, 11] as in (table 1) 
show differences between these main criteria [5]. 
In 2005, the International Diabetes Federation (IDF) issued new criteria that further modified the ATP III 
definitions [5, 18].This definition of IDF represents modifications of the WHO and ATP III definitions.  
1. Raised Triglyceride >150mg/dl or on treatment for this abnormal lipid.  
 2. Reduced High density lipoprotein<40mg/dl in male and <50mg/dl in female or on treatment for this 
abnormality.                                               
  3. Raised blood pressure >130/85mmhg or on treatment for hypertension.  
4. Raised fasting plasma glucose >100mg/dl or diagnosed as DM type 2. Definitions agreed on core component 
of MS, which included (hyperglycemia, obesity, dys- lipidaemia, and hypertension), but they differed in the 
details and criteria [5]. 
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Table (1): Criteria for clinical diagnosis of MS. 
Clinical Measure  WHO  ATP III  AHA/NHLBI 
Waist Circumference 
 
 
   
≥102 cm in men, 
≥88 cm in women 
 
 
Same as ATP III 
       
BMI  BMI >30 kg/m2       
Triglycerides   ≥150 mg/dL  Same as WHO  Same as WHO 
HDL-C   
<35 mg/dL in men, 
<39 mg/dL in 
women 
 
 
 
 
<40 mg/dL in men, 
<50 mg/dL in women 
 
 
Same as ATP III 
       
Blood Pressure  ≥140/90 mm Hg  ≥130/85 mm Hg  Same as ATP III 
       
Glucose   
IGT, IFG, or 
NIDDM 
 
Fasting >110 mg/dL 
(IFG) 
 
 
Fasting ≥100 mg/dL (IFG) 
Insulin Resistance  YES  NO  NO 
Micro albuminuria  YES  NO  NO 
     
Main component of MS  
  1- Obesity:  
  The global epidemic of overweight and obesity - "globosity" - is rapidly becoming a major public health 
problem in many parts of the world, and they are the serious risk factors for a number of chronic diseases, 
including DM, CVD, and cancer. Overweight and obesity are the fifth leading risk for global deaths [23]                 
        According to WHO, Overweight and obesity are defined as abnormal or excessive fat accumulation that 
may be risk to the health [23].A crude population measure of obesity is the body mass index (BMI) which is 
equal to body weight in kilograms divided by the height in meters squared (BMI =Weigh kg/High m2) and the 
values of BMI are age independent and same for both sexes as in table 2 [23].                               
           Because a body mass index (BMI) provides little information on the location of body fat, only useful as 
an initial step towards crudely classifying patients based on their relative weight so there are additional methods 
to measure abdominal fat exist, such as waist circumference (WC) and waist to hip ratios (WHR) [24]. 
Measuring waist circumference (WC) is the simplest accurate anthropometrical indicators of central obesity 
[25,26].  In the measuring of (WC) as BMI, there is cut off values have been set to identify increased risk, but for 
(WC) need to be sex and population specific [25]. The (WC) can be measured at the midpoint between margin of 
last rib and iliac crest which is considered as an indicator of risk if >88cm in female and >102cm in male [5, 
16] .The hip circumference (HC) can measure at a level of a greater trochanter, the (WHR)>1 in male and >0.85 
in female consider as an indicator of risk of metabolic and CV complication of obesity [16, 24] 
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Table (2): BMI classification, the International Classification of adult underweight, overweight and obesity 
according to BMI (23).                    
Classification BMI(kg/m2) 
 
Principal cut-off 
points 
Additional cut-off 
points 
Underweight <18.50 <18.50 
     Severe thinness <16.00 <16.00 
     Moderate thinness 16.00 - 16.99 16.00 - 16.99 
     Mild thinness 17.00 - 18.49 17.00 - 18.49 
Normal range 18.50 - 24.99 
18.50 - 22.99 
23.00 - 24.99 
Overweight ≥25.00 ≥25.00 
     Pre-obese 25.00 - 29.99 
25.00 - 27.49 
27.50 - 29.99 
     Obese ≥30.00 ≥30.00 
          Obese class I 30.00 - 34.99 
30.00 - 32.49 
32.50 - 34.99 
          Obese class II 35.00 - 39.99 
35.00 - 37.49 
37.50 - 39.99 
          Obese class III ≥40.00 ≥40.00 
                             
2  . Diabetes mellitus type 2 and insulin resistance:   
            The term Diabetes mellitus (DM) describe a chronic metabolic disease which occurs when the pancreas 
does not produce enough insulin or when the body cannot effectively use the insulin, it produces; this can lead to 
an increase of glucose of the blood (hyperglycemia) [27].              
classified as type 1, type 2, other specific types of diabetes (e.g., secondary diabetes), and gestational DM  
diabetes [27,28].          
 
3 Hypertension: 
      Systemic blood pressure(BP) rises with age, and the incidence of CVD is closely related to averaging( BP) at 
all ages, and the CV risk associated with BP are dependent the combination of risk factors such as age, gender, 
weigh, physical inactivity, smoking, family history, serum cholesterol, DM, and preexisting CVD[26] which 
similar to risk factors of MS. Therefore, the hypertension is a highly prominent feature of the MS, present in up 
to 85% of patients [29,30].           
4 Atherogenic dyslipidemia: 
     Atherogenic dyslipidemia comprises a triad of increased blood concentrations of small, dense low-density 
lipoprotein (LDL) particles, decreased high-density lipoprotein (HDL) particles, and increased triglycerides. It 
was emerged as an important risk factor for myocardial infarction and CVD [31]. the triglycerides/HDL-C ratio 
has been shown to be an athero genic marker that links insulin resistance to CVD [31].                    
         5 . A pro inflammatory state: 
         It is characterized by elevations of circulating inflammatory molecules such as C-reactive protein (CRP), 
tumor necrosis factor-alpha, plasma resistin, interleukin (IL)-6, and IL-18. CRP is a general marker of 
inflammation that has been linked to CVD in patients with MS [32].     Elevated levels of CRP are associated 
with many of the clinical features of the MS like increased waist circumference [32, 33].  
6. Prothrombotic state:    
             Also called hemostatic abnormality characterized by increased level of plasma plasminogen activator 
inhibitor type 1 (PAI)-1 associated with hypo fibrinolysis, it considered to be the core feature of MS because 
closely associated with other components [5, 34] and responsible for thrombotic complication.                       
Others risk factors associated with MS are eating the inappropriate amounts and types of foods ,smoking ,  not 
exercising and having too much stress in the life [16,35] are the most importantly factors. The rate of chronic 
stress, combined with immobilization, wrong nutrition, depression and fear of social changes with run in families 
have increased statistically the prevalence of MS, DM and obesity in the US [36, 37].also women with 
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Polycystic ovary syndrome (PCOS)  have 11-fold increase in the prevalence of MS compared with female have 
no PCOS [38] .also the MS increases in menopause women with the emergence or worsening of some risk 
factors: central obesity, systemic hypertension and dyslipidaemia.  [39]. MS can also cause damage to the lining 
of coronary and other arteries; a key stepped toward the development of coronary heart disease also atrial 
fibrillation, heart failure, aortic stenosis, and ischemic stroke [6, 40]. it is found that between 1990 and 2020, 
mortality from CVD in developing countries is expected to increase by 120% for women and 137% for man who 
is expected to be substantially greater than from developed countries (29% and 48%, respectively) [16, 41] .In 
Iraq, found that the prevalence of MS was very much higher among patients with CVD (84%) than those without 
CVD (10%) [12]. Therefore, the preventive measures to control MS as  consistent exercise routine  , Commit to a 
healthy diet and Losing Weight and regular Checking the blood pressure, cholesterol and blood sugar levels 
regularly are important  [40, 41,42].         
There was no previous study in Babylon Governorate in Iraq about evaluation the risk factors that may be 
responsible for development of MS and even in surrounding Arab countries,    . 
So This study was conducted to evaluate the risk factors for the development of MS in order to put certain 
preventive methods to decrease the incidence of some preventable risk factors associated with MS in Babylon 
Governorate, 2012                                          
 
Patients and methods 
          Across sectional study was conducted in Hilla city. Our study was done in a Merjan teaching hospital (out 
patient's clinic).Data collection was carried out during the period from 1st of April to 30 of June 2012.                                
        The total patients collected were 380 patients (200 females and 180 males) with age ≥ of nineteen years old. 
About 30 patients refuse to participate in the study .The main reasons for a non-participant were fatigue or being 
too ill. Other 35 patients did not bring complete investigation. SO, a total of 315 out of 380 of an eligible patient 
took part in the study (177 were females, and 138 were males).                                 
   All the patients are randomly selected when attending the out patient's clinic in a Merjan teaching hospital 
during the time of study who accepted to participate in the study, Those patients with age ≥ 19 years old were  
included in the study while            Any patient had DM type 1 or other chronic diseases like chronic renal failure, 
malignancy, and history of IHD and age< 19 years old, pregnant women  and those who refuse to participate in 
the study Were excluded from this study.   
   Data collection tools: 
       A specially designed data sheet was used; to assess the risk factors of MS of randomly selected patients from 
out patient's clinic in Mirjan hospital and this sheet contain:                                                                      
1. Questionnaires. 
2. Blood pressure and anthropometric measurements (weight, height, BMI, WC, WHR).  
3. Biochemical investigations and abdominal ultrasound. 
      The Questionnaires;Divided into four sections: 
 Section 1:include socio demographic factors :- name, age(divided into three age groups 19-39,40-59,and >60 
years old), gender, residence (rural and urban) , occupation (Government employed, self-employed and un 
employed), type of diet ( if rich with CHO and fat or not), eating disorders like eating at night, physical inactivity 
( less than 3 hours /week) and smoking [10].                                                                    
 Section 2: include health-related risk factors: - such as history of chronic disease (DM type 2, Hypertension, 
Hyper lipidemia) or on treatment for them, chronic stress, anxiety, (fatty liver and Gall bladder diseases) by 
abdominal ultrasound, sleep disturbances, and family history of DM, Hypertension, IHD or Obesity [10].              
  Section 3: include factors related to female such as PCOS (polycystic ovarian syndrome), MD (menstrual 
disturbance), and menopause.               
  Section 4: include factors related to male (premature anginal chest pain, premature sexual problem, and alcohol 
abuse).                                  
                          
     The Risk assessment: We deepened in our results on NCEP/ATPIII definition of MS and the risk score 
assessment of MS as the study done in US [10].According to this score, we give to each abnormal finding (yes) 
and to each normal result (no), and then we count each (yes) answer as one point and add them up while (no) 
answers are zero points. If the total score is less than 10 mean, the patients had low risk of MS. If the score is 
higher than 20, mean the patients at high-risk and if the score is between 11 to 19 indicator of moderate risk of 
MS.                                                  
Data Analysis: 
Recording information was checked for missing values and data entry errors. Statistical analysis was performed 
using Statistical Package for Social Science software (SPSS, version 17) and Microsoft office Excel 2010 was 
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used for data processing and statistical analysis. Variables were described using frequency distribution and 
percentage for the patients according to their characteristics and mean (-x); standard deviation (SD) for 
continuous variable .The chi-squared test was used for the assessment of association between the variables 
studied. The p- value of less than 0.05 was significant statistically.  
Limitations of this study:  
1-Not all responders gave their consent to fill the questionnairee. 
2. Limited time for data collection.2 
3.The findings of this study are limited by the use of the sample of patients from just one hospital, which is 
maybe not a representative of all populations in Hilla city                                                                               
4.The data are based on self-reports of the patients, possibly leading to under or over reporting therefore, 
information bias cannot be excluded.  
                             
Results :  
         the total number of patient collected to these study (315) patients. The minimum age 19 years old and 
maximum 76 years old with mean age ± standard deviation (47.70±13.49 SD). Among those patients (24.1%) are 
government employed, (24.2%) are self-employed and (51.7%) unemployed). About (71.1%) of participants 
lived in urban area while (28.9%) lived in a rural area. In this study the number of the females about 177 (56.2%) 
with mean of the age± standard deviation (46.54±13.72 SD) and 138 (43.8%) male, their age mean ±standard 
deviation (49.19±13.09 SD).Then we classified the total number of patients into three risk groups of MS 
according to the number of risk factors. The overall proportions of these risk groups were low risk groups, 
moderate risk groups and high risk groups as (31.1%), (50.8%) and (18.1%) respectively as in table (3).  
    According to our questionnaire sheet in which we classified into female and male, some tables also divided 
according to the gender.                      
            (Table 4) shows the female's socio demographic   characteristics, the main age group between 40-60 
years old (44.1%) and most of the female lived in urban area (76.3%). Majority of female were unemployed 
(74.6%).The percentage of the female consumed diet rich with carbohydrate and fat, physical inactivity, cigarette 
smoking, sleep disturbance and chronic stress were (63.3%), (84.7%), (6.8%), (65.5%), and(84.2%)respectively.  
(Table 5) shows the distribution of a female study group according to health-related factors; we found the 
females with overweight and obese were (43.5%) and (26.6%) respectively but those with central obesity was 
(89.3%).The percentage of other factors like hypertension,  DM, low HDL, high triglyceride, PCOS, menstrual 
disturbance, menopause, gall bladder disease and fatty liver were 
(52.0%) ,(42.4%) ,(40.7%) ,(45.8%) ,(19.2%) ,(60.5%) , (47.5%), (18.1%)  and (4.5%) respectively(Table 6) 
shows the distribution of a male study group by demographic characteristics in which the main age group 
between 40-60 years old with percentage (51.4%). Majority of the male sample lived in urban area (64.5%), and 
most of them were self –employed (47.8%). The percentage of males with unhealthy diet, physical inactivity, 
smoking, sleep disturbances and chronic stress were (48.6%), (81.9%), (65.9%), (65.2%), and (82.6%) 
respectively. 
       (Table 7) shows the distribution of health-related  factors in males, the overweight and obesity were (35.5%) 
and (32.6%) respectively while central obesity about (77.5%).Other factors like hypertension, DM, low HDL, 
high triglyceride, family history of chronic disease and premature heart disease their percentages were (55.8%), 
(47.8%), (18.1%), (55.1%), (67.4%) and (27.5%) respectively..   Table (8) shows the high frequency distribution 
of many of risk factors central obesity, low HDL, gall bladder diseases and types of diet (89.3%), (40.7%), 
(18.1%) and (63.3%) respectively among females more than male (77.5%), (18.1%), (7.2%) and (48.6%) 
respectively with statistical association of these factors to female (p-value=0.005, 0.000, 0.005, and 0.009) 
respectively. While in male, there was high frequency distribution with statistical association to smoking (65.9%) 
than (6.8%) in female with (p-value=0.000). 
In related to risk assessment score as in (table 9) shows the distribution of risk score according to gender, we 
found that higher percentage of females (53.1%) were moderate risk for development of MS while for males 
were (47.8%) and there was no statistical significant association between gender and risk for MS with p 
value=0.648.   There was statistically significant association between the risk for development of MS to an age 
group's with (p-value= 0.002) as in (table 10) the distribution of risk groups for development of MS according to 
age, there was about (60%) of patients >60 years had moderate risk for developing of MS, (23.1%) at high-risk 
and only (16.9%) at low risk for development of MS within the same age group. While at age groups between 
40-60 years, there was (53%) had moderate risk, (19.5%) to be at high-risk and (27.5%) at low risk for 
developing of MS(Table 11) shows, the association of other health factors to risk score was highly significant 
association for the risk to development of MS with hypertension and triglyceride mainly among high-risk group 
(71.9%) and (73.7%) respectively with (p value=0.000). There was statistical significant association of risk score 
Journal of Natural Sciences Research                                                                                                 www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) 
Vol.3, No.6, 2013 
 
122 
to BMI, central obesity, DM, low HDL, type of diet, and physical inactivity with p value = (0.048), (0.043), 
(0.017), (0.018), (0.019), and (0, 004) respectively. 
      (Table 12) show, the association of female's risk factors for development of MS and there was a statistical 
relation to menopause, mainly among the high risk groups (61.3%) with (p-value= 0004) but there was no 
statistical association to PCOS with (p-value= 0.427). 
   
Table 3: Distribution of study group by risk score. 
Risk score number %  
 <10(Low risk) 98 31.1 
11-19 (Moderate risk) 160 50.8 
>20 (High risk) 57 18.1 
   
Total 315 100.0 
    
       
Table( 4): Distribution of the female's socio demographic characteristics. 
 
 
 
 
 
              
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                   
  
  
 
  
 
 
 
 
 
 
 
 
 
% Number Characteristics  
  
37.3  
44.1 
18.6 
 
  
66 
78 
33 
  
Age groups 
19-39 years 
40-59 years 
>60 years 
 
  
76.3 
23.7 
  
135 
42 
Address  
Urban 
Rural  
  
19.8 
 
5.6 
74.6 
  
35 
  
10 
132 
Employment 
    Government employed 
Employed Self 
Unemployed  
  
 
63.3 
36.7  
  
 
112 
65 
Type of diet(rich with CHO and 
fat)   
        YES 
NO 
  
  
84.7 
15.3 
  
  
150 
27  
Physical inactivity<3hr/week 
YES 
NO 
  
  
6.8 
93.2 
 
 
12 
165  
  
Smoking 
Yes 
No  
  
65.5 
34.5 
  
116 
61 
Sleep disturbance 
Yes  
No 
  
84.2 
15.8 
  
149 
28 
Chronic stress 
Yes 
No 
Journal of Natural Sciences Research                                                                                                 www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) 
Vol.3, No.6, 2013 
 
123 
Table (5): Distribution of health-related factors in the females.  
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
%  Number Characteristics  
  
5.0 
21.5 
43.5 
26.6 
3.4 
  
9 
38 
77 
47 
6 
BMI(BW/HT2)  
<18.5  
18.5-24.9 
25-29.9 
30-39.9 
>40  
  
89.3 
10.7 
  
158 
19 
Central Obesity (WHR) 
Abnormal>0.85 
Normal<0.85  
  
52.0 
 
48.0 
 
92  
  
85  
Blood Pressure  
>140/90 Or On Treatment 
 
Normal  
  
42.4  
57.6 
 
75 
102 
Fasting Blood Sugar 
>110mg/dl Or On Treatment  
Normal  
  
40.7 
59.3 
  
72 
105 
High density lipoprotein(HDL)  
Abnormal<50mg/dl 
Normal  
  
45.8 
54.2 
  
81 
96 
Triglyceride (TG) 
>150mg/dl 
Normal  
  
  
19.2 
80.8 
 
  
  
34 
143 
 
Polycystic ovarian syndrome (PCOS) 
Yes 
No 
  
  
60.5 
39.5 
  
107 
70 
Menstrual disturbance  
          Yes  
          No 
 
75.1 
24.9 
  
  
133 
44 
 
Family history of chronic 
disease(DM,CVD, central obesity) 
Yes 
No  
  
47.5 
52.5 
 
  
84 
93 
Menopause 
Yes 
No 
  
  
18.1 
81.9 
  
32 
145 
Gall bladder disease 
Yes 
No  
  
4.5 
95.5 
  
8 
169 
Fatty liver 
Yes 
No  
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Table (6): Distribution of the socio demographic characteristics in the male. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
% Number Characteristics  
  
25.4  
51.4 
23.2 
 
  
35 
71 
32 
  
Age groups 
19-39 years 
40-59 years 
>60 years 
 
  
64.5 
35.5 
  
89 
49 
Address  
Urban 
Rural  
  
29.7 
47.8 
22.5 
  
41 
66 
31 
Employment 
    Government employed 
Employed Self 
Unemployed  
  
 
48.6 
51.4  
  
 
67 
71 
Type of diet(rich with CHO 
and fat)   
        YES 
          NO 
  
  
81.9 
18.1 
  
  
113 
25  
Physical inactivity<3hr/week 
YES 
NO 
  
  
65.9 
34.1 
 
 
91 
47  
  
Smoking 
Yes 
No  
  
65.2 
34.8 
  
90 
48 
Sleep disturbance 
Yes 
No 
  
82.6 
17.4 
  
114 
24 
Chronic stress 
             Yes 
No 
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Table (7): Distribution of the health related factors in the male. 
 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (8): Distribution of socio demographic and health related factors to the gender. 
Characteristics Gender  
Chi-square 
 
p-value Female % Male % 
Central obesity 89.3% 77.5% 7.989 0.005 
Low HDL 40.7% 18.1% 18.522 0.000 
Gall bladder diseases  18.1% 7.2% 7.875 0.005 
Types of diet 63.3% 48.6% 6.854 0.009 
Smoking 6.8% 65.9% 123.333 0.000 
   
 
        
 
 
 
% Number Characteristics  
  
4.4 
24.6 
35.5 
32.6 
2.9 
  
6 
34 
49 
45 
4 
BMI(BW/HT2) 
<18.5 
18.5-24.9 
25-29.9 
30-39.9 
>40  
  
77.5 
22.5 
  
107 
31 
Central Obesity (WHR) 
Abnormal>1 
Normal<1  
  
55.8 
 
44.2 
 
77  
  
61  
Blood Pressure  
>140/90 Or On Treatment 
 
Normal  
  
47.8  
52.2 
 
66 
72 
Fasting Blood Sugar 
>110mg/dl Or On Treatment  
Normal  
  
18.1 
81.9 
  
25 
113 
HDL  
Abnormal<40mg/dl 
Normal  
  
55.1 
44.9 
  
76 
62 
Triglyceride 
Abnormal>150mg/dl 
Normal<150mg/dl 
  
 
67.4  
32.6 
  
  
 
93 
45 
Family history of chronic 
disease(DM,CVD, central obesity)  
Yes 
No  
  
7.2 
92.8 
  
10 
128 
Gall bladder disease 
Yes  
No  
  
3.6 
96.4 
  
5 
133 
Fatty liver 
Yes 
No  
  
 
27.5 
72.5 
  
 
38  
100 
Premature heart disease or chest pain  
Yes 
No 
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Table (9): Distribution of risk groups for development of MS according to the gender. 
Risk groups Gender P-Value 
Female Male 
 
 
 (Low risk) number 52 46  
 
 
0.648 
% 29.4 33.4 
 (Moderate risk) number 94 66 
%  53.1 47.8 
 (High risk) number 31 26 
%  17.5 18.8 
Total number 177 138 
%  100 100 
        
Table (10): Distribution of risk groups for development of MS according to age. 
   
Total 
 
p-value 
 
Risk groups Age groups 
19-39  
years old 
40-60 
years old 
>60 years 
old 
  (Low risk) Number  
46 
 
41 
 
11 
 
98 
 
 
 
 
 
 
0.002 
 
% 
 
45.5 
 
27.5 
 
16.9 
 
 (Moderate risk) Number 42 79 39 160 
% 41.6 53.0 60.0  
 (High risk) Number 13 29 15 57 
% 12.9 19.5 23.1  
Total Number 101 149 65 315 
% 100 100 100  
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Table 11: Distribution the risk groups for metabolic syndrome according to the health related and demographic 
characteristics. 
 
 
 
 
 
 
 
 
p-value Chi-
square 
High-risk group 
Number  % 
Moderate risk 
group 
Number    % 
Low risk 
group 
Number % 
Characteristics 
 
0.048 
 
 
 
 
 
15.025 
 
6           10.5 
11            19.3 
23           40.4 
17            29.8 
0           0.0 
 
2             1.2 
35           21.9 
69           43.1 
46            28.8 
8              5.0 
 
7         7.1 
26      26.5 
34      34.7 
29      29.6 
2         2.1 
BMI 
<18.5 
18.5-24.9 
25-29.9 
30-39.9 
>40 
 
0.043 
 
 
6.294 
 
49             86.0 
8               14.0 
 
141        88.1 
19         11.9 
 
75     76.5 
23     23.5 
Central obesity 
Yes 
No 
 
0.000 
 
19.890 
 
41        71.9 
16          28.1 
 
 
92       57.5 
68       42.5 
 
 
36     36.7 
62     63.3 
 
High blood pressure 
Yes 
No 
 
0.017 
 
8.136 
 
35         71.9 
22        28.1 
 
 
68         42.5 
92        57.5 
 
 
38      38.8 
60     61.2 
 
High blood sugar 
Yes 
No 
 
0.018 
 
8.059 
 
23        40.4 
34       59.6 
 
54      33.8 
106      66.2 
 
20   20.4 
78   79.6 
Low HDL 
Yes 
No 
 
0.000 
 
20.787 
 
42       73.7 
15         26.3 
 
80        50.0 
80          50.0 
 
35    35.7 
63    64.3 
High Triglyceride 
Yes 
No 
 
 
0.069 
 
 
5.353 
 
 
 
35        61.4 
22        38.6 
 
 
 
123       76.9 
37       23.1 
 
 
 
68      69.4 
30      30.6 
Family history of chronic 
disease 
 
Yes 
No 
 
o.762 
 
0.545 
 
21            36.8 
36            63.2 
 
51          31.9 
109         68.1 
 
31      31.6 
67      68.4 
Smoking 
Yes 
No 
 
0.145 
 
3.860 
 
48               84.2 
9               15.8 
 
139        86.9 
21         13.1 
 
76     77.6 
22     22.4 
Chronic Stress 
Yes 
No 
 
 
0.019 
 
 
7.890 
 
 
32        56.1 
25         43.9 
 
 
102        63.8 
58         36.2 
 
 
45     45.9 
53      54.1 
Type of diet 
 
Yes 
No 
 
 
0.004 
 
 
11.182 
 
 
48        84.2 
9           15.8 
 
 
143    89.4 
17        10.6 
 
 
72   73.5 
26   26.5 
Physical inactivity 
 
Yes 
No 
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Table 12: Distribution of female's health related factors according to risk groups for MS.                                   
                                                     
  
 
Discusion :   
          Metabolic syndrome (MS) is a complex disorder with high socioeconomic cost that is considered a 
worldwide epidemic. Although the presence of main criteria for MS can predict the risk of CVD and type 2 DM, 
but it cannot estimate the exact risk, as a significant part may be related to other factors such as smoking, type of 
diet, physical inactivity, age, and gender [32]. There are few international comparable studies of the risk 
assessment of MS among adult patients, but we could not find similar studies from nearby Arabic countries only 
study in US about global risk assessment of MS in adult by using a Framingham risk score [32].                            
   In this study, the majority of patients (50.8%) were in moderate risk for developing MS, and it was more 
prevalent in female (53.1%) than male (47.8%) when compared to study done in US, found that high prevalence 
of low-risk group and it is more in female than male [32].This may be indicated to increase awareness of 
population in developed countries about many modifiable risk factors of MS compared to developing countries.   
                                                                                 
            This study shows, there was high frequency distribution of most of metabolic risk factors among female 
compare to male like central obesity, type of diet, low HDL, and gallbladder diseases (89.3%),  (63.3%), 
(40.7%), and (18.1%) with p-value (0.005), (0,009), (0.000), and (0.005) respectively while in male, the 
frequency was (77.5%), (48.6%), (18.1%), and (7.2%) respectively but there was no statistical association in 
male. There was no statically association of gender to other socio demographic and health related factors like  
(hypertension, DM, obesity and increase TG), the frequency between female were (52.0%), (42.4%), (26.6%), 
(45.8%) and in male (55.8%), (47.8%), (32.6%), (55.1%) respectively . This result was consistent with data 
collected by WHO in Iraq in 2005 found overweigh and obesity were (50.8%), (16.8%) and it was higher among 
female than male [25] and consistent with study in India found there was higher prevalence of central obesity 
among female than male [16]. The  exact explanation of such gender variations was not entirely clear, it may 
attributed to women are less active compared with men ,limited exercise facilities for women, lack of physical 
education, sedentary lifestyle, unhealthy diet(rich with carbohydrate and fat) and absence of women's 
participation in organized sports.                                 
                 While in male, there was only high frequency and highly significant association of cigarette smoking 
(65.9%) with p-value=0.000 more than female (6.8%) which may be attributed to universally high incidence of 
smoking among males compare to the female.                         
         Also, in this study there was no statistical association of risk groups for development of MS to the gender 
although there was higher frequency of the moderate risk groups in female (53.1%) and (47.8%) in male with (p-
value= 0.648) consisting with study done by Bamashmoos M.A. and et al in Yemen [20] found no gender 
variation in related to MS about (46.4%) in female and (45%) in male , in addition to study in Brazil found 
(33.0%) in female and (30.9%) in male [3].It  was inconsistent with study done in Saudi Arabia [2] in which 
higher prevalence among male (22.8%) than (13.8%) in female with p-value 0.001 while study in Turkey shows 
higher among female (39.6%) than (28%) in male [18].                   
      The study shows statistical significant association of risk groups for development of MS to the age (p-value= 
0.002) mainly among the moderate risk groups which was higher prevalence (53%) and (60%) among age 
groups (40-60 years) and (> 60 years) respectively, and this result was in good agreement with study done by 
p-value Chi-
square 
High risk 
group 
Number  % 
Moderate risk 
group 
Number   % 
Low risk group 
 
Number   % 
Characteristics 
 
 
0.004 
 
 
 
 
 
10.842 
 
19         61.3 
 
12         38.7 
 
50         53.2 
 
44         46.8 
 
  15      28.8 
 
   37      71.2 
 
Menopause 
Yes 
 
No 
 
 
0.427 
 
 
1.701 
 
6           19.4 
 
25         80.6 
 
21         22.3 
 
73         77.7 
 
7           13.5 
 
45         85.5 
 PCOS 
                        Yes 
 
                          No 
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Juda T.M. and et al in Hilla city [11], and other studies done in Saudi Arabia [2], Pakistan [15], Norwege [14], 
US [22,32] and in Brazil [37]. All these studies found that prevalence of MS increases with age may be indicated 
to increase the incidence of risk factors like obesity, DM, and hypertension with aging. 
        In this study, there was highly statistical significant association of risk for development of MS to 
hypertension mainly among the high-risk group (71.9%) with (p-value= 0.000). This result supported by study in 
Basrah in 2007 by Mansour A.A found higher prevalence of hypertension among the study groups (76.5%) [13], 
other study in Yemen in 2011 found (68%) have hypertension [20], and the study of American Heart Association 
statistical updated in 2011 found (33.5%) of US adult have hypertension [31].This may be attributed to 
hypertension associated with many laboratories and anthropometric abnormal findings, which linked to MS such 
as central obesity that recognized hypertension as main factors involved in pathophysiology of MS and also may 
be indicated to genetic predisposition factors [10]. 
        There was highly statistical association of risk groups to elevated triglyceride, mainly among the high-risk 
group (73.7%) with (p-value= 0.000) this result was   consisting with study done in Basrah found (69%) of the 
study group have increased TG [13], in Yemen study also found about (66%) of population have hyper 
triglycrideamia [20]. This result of high prevalence of TG may be attributed to type of diet, physical inactivity 
and central obesity or may be due to genetic causes [20]. 
       There was statistical significant association between the risk for development of MS to overweight and 
obesity among moderate risk group (43.1%) and (28.8%) respectively, with (p-value= 0,048) and it was higher in 
female than male similar to many studies such as study done by Juda T.M. and et al in Hilla city [11] in addition 
to studies done in Saudi Arabia [2], Kuwait [25] and in Iran [16]. Also, this study shows significant association 
of risk for development of MS with central obesity among moderate risk group (88.1%) with (p-value= 0.043) 
and it was higher in females than males which agree to the study in Oman that found higher prevalence of central 
obesity mainly among female (64.6) and (31.5%) in male [18], Yemen [20]  and in Iran (42% for female and 24% 
in male) [16]. While inconsistent with study done in Basrah found the prevalence of central obesity about (66.5%) 
and it was higher in male than female [13].  
        The study shows significant statistical association of risk for development of MS with DM type 2, mainly 
among high-risk groups (61.4%) with (p-value= 0.017) consisting with study done in Saudi Arabia [2] and in 
Pakistan [15].This may be attributed genetic factors or to increase prevalence of central obesity, which was 
considered as risk factors to DM type 2 and also related to unhealthy diet [28]. 
        There was statistical significant association of risk to development MS with low HDL among the high-risk 
group (40.4%) with ( p-value= 0.018) which consistent with study done in Basrah found about (45%) of the 
patients with MS have low HDL[13], study done in Yemen found about (64%) of patients with MS complain 
from low HDL [20], study in Saudi Arabia [2] and with study done by Ahmad M., and et al in Pakistan found the 
frequency of low HDL was (87.6%)[15]. This was explained by the physical inactivity, genetic predisposition, as 
well as dietary habits. 
       The study shows, a significant association of the risk for development MS with type of diet (rich with 
carbohydrate and fat) and physical inactivity, among the moderate risk groups (63.8%), (89.4%) with (p-value= 
0.019 and 0.004) respectively and mainly among females than males. This consisting with many studies [16, 20, 
25] which may be related to high prevalence of obesity and central obesity in developing countries and relation 
to sedentary lifestyle and unhealthy diet. 
        In females health related risk factors, we found there was statistical significant association of risk for 
development MS among moderate risk group to menopause (53.2%) with (p-value=0.004) similar to cross-
sectional study done in Brazil in 2010 found (44.4%) of menopausal women have risk of MS [39], and cross-
sectional study in Latin America found (42%) of the study group of menopausal women have risk of MS 
[19].This may be indicated to that female in postmenopausal have higher risk than premenopausal to develop MS 
due to coincides with the climacteric, hormonal effect, and menopause was characterized by the emergence or 
worsening of some risk factors: central obesity, systemic hypertension and dyslipidaemia [39]. But we found 
there was no statistical significant relation of a risk to MS with PCOS (p-value=0.661) which is inconsistent with 
case-control study done in University of Iowa found significant association of risk to MS with PCOS [38]. This 
may be attributed to the sample size, and the study was done in a medical hospital while most females with 
PCOS attending gynecological hospital.                                                                                                
Conclusions: 
*The study demonstrates that MS is a multifactorial problem. It shows that (obesity, central obesity, type of diet 
and physical inactivity) are main modifiable risk factors to MS mainly in moderate risk group. Therefore, public 
health programs should consider these factors when planning strategies aimed at preventing or reducing 
incidence of MS in our society.  
*This study provides comprehensive and alarming data about the high percentage of many traditional risk factors 
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of MS (central obesity, DM, hypertension, dyslipideamia) among the population of Babylon especially in 
females and this risk increase with advancing the age. The results suggest that reducing health education 
inequalities may be an important public policy goal to improve health outcomes mainly among females.  
              
Recommendations:  
* The results of this study have to be further assessed using a more elaborate analytical study and enrolling a 
bigger sample size.                
* The high proportion of risk factors mainly in moderate risk group for MS mandates the conduct of community 
based surveys for early recognition and prevention of MS and associated risk factors and to reduce the impact of 
MS on the community.                                                                                            
*As MS is considered global health problem and because the central obesity was the main preventable risk factor, 
the nutrition and health promotion programs should be encouraged to promote healthy life style and to improve 
the awareness of population and mainly health workers about nutrition and healthy eating habits and to reduce 
the tendency to overweigh and obesity.  
*The risk of MS is high even at a young age female with PCOS, highlighting the importance of early and regular 
screening for PCOS. 
*This is the may be the first study about the risk assessment of MS in Babylon; its results provide valuable 
information on the risk factors of MS in such high risk group and should encourage researchers to investigate 
more such an emerging, health problem. 
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